Coherent Opts for II-VI Takeover, Will Terminate Existing Lumentum Agreement - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Coherent Opts for II-VI Takeover, Will Terminate Existing Lumentum Agreement

    Article obtained from Photonics RSS Feed.

    II-VI will enter into a definitive agreement with Coherent, allowing the Pittsburgh-based optical components and semiconductor materials manufacturer to acquire Coherent. The deal is worth around $7 billion.

    Accordingly, Coherent said, it is terminating a merger agreement with Lumentum, which the two companies entered on March 9. Coherent will now pay Lumentum a termination fee of more than $200 million.

    Per terms of the II-VI/Coherent merger agreement, each share of Coherent common stock will be exchanged for $220 in cash and 0.91 of a share of II-VI common stock.

    Both companies, in separate press releases, said they expect the deal to close in the fourth quarter of 2021. II-VI said that it expects the combined company…

    READ MORE
    Mar, 25 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.